The effects of beta-blocker use on cancer prognosis: a meta-analysis based on 319,006 patients

Por Na, Zhijing, Qiao, Xinbo, Hao, Xuanyu, Fan, Ling, Xiao, Yao, Shao, Yining, Sun, Mingwei, Feng, Ziyi, Guo, Wen, Li, Jiapo, Li, Jiatong, Li, Dongyang
Publicado no Onco Targets Ther (2018)

The epidermal growth factor tyrosine kinase inhibitor AG1478 and erlotinib reverse ABCG2-mediated drug resistance

Por Shi, Zhi, Parmar, Smitaben, Peng, Xing-Xiang, Shen, Tong, Robey, Robert W., Bates, Susan E., Fu, Li-Wu, Shao, Yining, Chen, Yang-Min, Zang, Feiyang, Chen, Zhe-Sheng
Publicado em 2009